Bridgewater Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,000
Closed -$233K 246
2022
Q1
$233K Hold
2,000
0.06% 216
2021
Q4
$301K Sell
2,000
-100
-5% -$13.5K 0.07% 195
2021
Q3
$251K Buy
+2,100
New +$231K 0.07% 209

Other funds holding TNDM

Bridgewater Advisors's TNDM Position: Q2 2022 in Review

Bridgewater Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,000 shares — an estimated $233K sold.

Bridgewater Advisors first reported a position in TNDM in Q3 2021 and held it in 3 quarters. The position peaked at $301K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Bridgewater Advisors reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Bridgewater Advisors sold 2,000 Tandem Diabetes Care shares in Q2 2022, an estimated $233K.
  • Bridgewater Advisors first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 3 quarters.
  • Bridgewater Advisors's Tandem Diabetes Care position peaked at $301K in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Bridgewater Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.